Beyond the First Year: Epidemiology and Management of Late-Onset Opportunistic Infections After Kidney Transplantation
Transplant International · 26.02.2024 · 37
DOI: 10.3389/ti.2024.12065 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant International, online erschienen am 26.02.2024. Verfasst von V Esnault und 12 weiteren Autor:innen. Beteiligte Einrichtung: Assistance Publique-Hôpitaux de Paris (AP-HP), Service de Maladies Infectieuses et d'Immunologie Clinique, Centre Hospitalo-Universitaire (CHU) Henri…. Hauptthemen laut MEDLINE: Kidney Transplantation, Opportunistic Infections. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Late opportunistic infections (OI) occurring beyond the first year after kidney transplantation (KT) are poorly described and not targeted by prophylactic strategies. We performed a ten-year retrospective monocentric cohort study describing epidemiology, risk factors and impact of late OI occurring 1 year after KT. We included clinically symptomatic OI requiring treatment besides BK virus nephropathy. Control groups included early OI occurring in the first year after KT, and KT recipients without OI since KT and alive with a functional allograft at 1 year. Among 1066 KT recipients, 185 (19.4%) presented a first episode of OI 21.0 (8.0–45.0) months after KT: 120 late OI (64.9%) and 65 early OI (35.1%). Late OI were mainly viral ( N = 83, 69.2%), mostly herpes zoster (HZ) ( N = 36, 43.4%). Pneumocystis represented most late fungal infections ( N = 12/25, 48%). Compared to early OI, we reported more pneumocystis ( p = 0.002) and less invasive aspergillosis ( p = 0.01) among late OI. Patients with late OI were significatively younger at KT (54.0 ± 13.3 vs. 60.2 ± 14.3 years, p = 0.05). Patient and allograft survival rates between late OI and control groups were similar. Only age was independently associated with mortality. While late OI were not associated with higher mortality or graft loss, implementing prophylactic strategies might prevent such infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Assistance Publique-Hôpitaux de Paris (AP-HP), Service de Maladies Infectieuses et d'Immunologie Clinique, Centre Hospitalo-Universitaire (CHU) Henri Mondor, Créteil, France.
- Fédération Hospitalo-Universitaire TRUE InnovaTive theRapy for immUne disordErs, AP-HP, Henri Mondor Hospital, Créteil, France.
- INSERM, Centre d'Investigation Clinique 1430, Créteil, France.
- EpiDermE Epidemiology in Dermatology and Evaluation of Therapeutics, EA7379, Paris Est Créteil University UPEC, Créteil, France.
- AP-HP, Département Médico-Universitaire Médecine, CHU Henri Mondor, Créteil, France.
- AP-HP, Service de Microbiologie, Département de Prévention, Diagnostic et Traitement des Infections, CHU Henri Mondor, Créteil, France.
Zitieren
APA
Esnault, V., Hoisnard, L., Peiffer, B., Fihman, V., Fourati, S., Angebault, C., Champy, C., Gallien, S., Attias, P., Morel, A., Grimbert, P., Melica, G., & Matignon, M. (2024). Beyond the First Year: Epidemiology and Management of Late-Onset Opportunistic Infections After Kidney Transplantation. Transplant International, 37. https://doi.org/10.3389/ti.2024.12065
Vancouver
Esnault V, Hoisnard L, Peiffer B, Fihman V, Fourati S, Angebault C, et al. Beyond the First Year: Epidemiology and Management of Late-Onset Opportunistic Infections After Kidney Transplantation. Transplant International. 2024;37. doi:10.3389/ti.2024.12065
BibTeX
@article{Esnault2024,
author = {Esnault, V and Hoisnard, L and Peiffer, B and Fihman, V and Fourati, S and Angebault, C and Champy, C and Gallien, S and Attias, P and Morel, A and Grimbert, P and Melica, G and Matignon, M},
title = {Beyond the First Year: Epidemiology and Management of Late-Onset Opportunistic Infections After Kidney Transplantation},
journal = {Transplant International},
year = {2024},
volume = {37},
doi = {10.3389/ti.2024.12065}
}
EUVIMED